Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
19.39
-0.42 (-2.12%)
At close: May 8, 2026, 4:00 PM EDT
19.05
-0.34 (-1.75%)
After-hours: May 8, 2026, 5:54 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.64 billion as of May 8, 2026. Its market cap has increased by 409.58% in one year.
Market Cap
1.64B
Enterprise Value
1.01B
1-Year Change
409.58%
Ranking
Category
Stock Price
$19.39
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.64B, an increase of 93.56%. That is a compound annual growth rate of 14.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.64B | 60.25% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.74B |
| Palvella Therapeutics | 1.74B |
| Viridian Therapeutics | 1.71B |
| Nurix Therapeutics | 1.71B |
| Vericel | 1.70B |
| Innoviva | 1.70B |
| Ardelyx | 1.67B |
| Nuvation Bio | 1.67B |